Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-25 @ 2:04 PM
NCT ID:
NCT00436566
Group ID:
EG000
Title:
AC/PTL
Description:
Standard doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (80 mg/m\^2) x 12 with concurrent standard dose trastuzumab (weekly x 12, then repeat 3 weeks for an additional 9 months) plus daily lapatinib (modified to 750 mg during Paclitaxel + Trastuzumab + Lapatinib (PTL) and 1000 mg during trastuzumab + lapatinib (TL)) for a total of 12 months.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
17
Serious Number At Risk:
108
Other Number Affected:
107
Other Number At Risk:
108
Study:
NCT00436566
Results Section:
NCT00436566
Adverse Events Module:
NCT00436566